EU Sets Up Database Of National GMO Requirements To Facilitate ATMP Trials
Executive Summary
The European Commission has developed a database to help drug companies navigate the complex process of seeking environmental clearance from EU member states before they can initiate a clinical trial with ATMPs containing a genetically modified organism.